The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Sleep Disorder Market Through 2030?

The sleep disorder market has experienced substantial expansion in recent years. Its projected growth trajectory indicates an increase from $33.32 billion in 2025 to $38.23 billion in 2026, at a compound annual growth rate (CAGR) of 14.7%. Historically, this market’s development can be attributed to heightened awareness regarding sleep health, the rising occurrence of insomnia and sleep apnea, increased adoption of sleep diagnostic services, an expanding geriatric population, a surge in stress and lifestyle-related sleep issues, and the growing use of smartphones and wearable devices for sleep tracking.

The sleep disorder market is anticipated to experience substantial growth in the next few years, with projections indicating it will reach $65.51 billion by 2030, expanding at a compound annual growth rate (CAGR) of 14.4%. This expansion during the forecast period is primarily driven by factors such as the increased utilization of telemedicine services for sleep-related conditions, the growing adoption of wearable devices for sleep tracking, the rise in home-based diagnostic testing, the wider use of cognitive behavioral therapy applications, and heightened government initiatives promoting sleep health awareness. Significant trends expected during this period include advancements in wearable sleep monitoring technology, improvements in home-based sleep diagnostic tools, progress in AI-driven sleep analysis, innovative non-invasive therapies for sleep apnea, developments in telemedicine for sleep consultations, and enhancements in cognitive behavioral therapy applications.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30744&type=smp

What Market Drivers Are Helping Shape The Sleep Disorder Market Expansion?

Rising stress and anxiety levels are projected to fuel the expansion of the sleep disorder market. These levels signify the extent of psychological pressure and persistent worry in a population, frequently stemming from environmental, societal, or economic stressors. The rise in stress and anxiety is attributed to pressures in the workplace, with employees encountering increased workloads, strict deadlines, and uncertainty regarding their employment. Stress and anxiety contribute to sleep disorders by disturbing typical sleep cycles and making it harder to initiate or maintain sleep. They negatively impact overall health by hindering restorative sleep, resulting in tiredness, reduced mental function, and a greater susceptibility to long-term illnesses. For example, data from May 2024, released by the US-based American Psychiatric Association (APA), indicated that 43% of U.S. adults reported increased anxiety in 2024 compared to the prior year. This figure represents an increase from 37% in 2023 and 32% in 2022. Consequently, escalating stress and anxiety levels are a key factor driving the expansion of the sleep disorder market.

How Is The Sleep Disorder Market Structured Across Different Market Segments?

The sleep disorder market covered in this report is segmented –

1) By Disorder Type: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Circadian Rhythm Disorders

2) By Treatment: Cognitive Behavioral Therapy, Medication Therapy, Psychiatric Treatment, Behavioral Treatment

3) By Diagnostic Method: Polysomnography, Home Sleep Testing, Actigraphy, Sleep Diaries, Questionnaires and Screening

4) By Distribution Channel: Retail Pharmacies, Online Sales, Hospital Pharmacies

5) By End-User: Hospitals And Sleep Centers, Home Care Settings, Academic

Subsegments:

1) By Insomnia: Acute Insomnia, Chronic Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia, Medication-Induced Insomnia

2) By Sleep Apnea: Obstructive Sleep Apnea, Central Sleep Apnea, Complex Sleep Apnea Syndrome, Mild Sleep Apnea, Moderate Sleep Apnea, Severe Sleep Apnea, Pediatric Sleep Apnea, Treatment-Resistant Sleep Apnea

3) By Restless Legs Syndrome: Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome, Mild Restless Legs Syndrome, Moderate Restless Legs Syndrome, Severe Restless Legs Syndrome, Intermittent Restless Legs Syndrome, Chronic Persistent Restless Legs Syndrome

4) By Narcolepsy: Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia, Pediatric Narcolepsy, Treatment-Resistant Narcolepsy, Secondary Narcolepsy

5) By Circadian Rhythm Disorders: Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Shift Work Sleep Disorder, Jet Lag Disorder, Irregular Sleep-Wake Rhythm Disorder, Non-24-Hour Sleep-Wake Disorder

What Trends Are Affecting The Sleep Disorder Market Dynamics?

Leading companies within the sleep disorder market are concentrating on developing advanced therapeutic technologies, including electrical vestibular nerve stimulation (VeNS) methods. This focus aims to provide non-drug treatment options that enhance sleep quality, regulate circadian rhythms, and support patients dealing with chronic insomnia. The electrical vestibular nerve stimulation (VeNS) method itself is a non-invasive therapeutic approach that delivers low-level electrical pulses to the vestibular nerve, a key neural pathway that influences brain regions involved in sleep regulation without the need for surgical intervention or pharmaceuticals. As an illustration, in October 2024, Neurovalens Ltd., a UK–based health-tech company, launched Modius Sleep. This FDA-cleared, non-invasive device is specifically designed to treat chronic insomnia using electrical vestibular nerve stimulation (VeNS). The headset-style medical device is worn for about 30 minutes each evening, transmitting safe electrical pulses to the vestibular nerve to influence the hypothalamus and brainstem areas that govern circadian rhythm and sleep patterns, thereby assisting users in falling asleep more quickly and remaining asleep for longer periods.

Which Companies Form The Competitive Landscape Of The Sleep Disorder Market?

Major companies operating in the sleep disorder market are Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Biogen Inc., Union Chimique Belge S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Limited, H. Lundbeck A/S, Sumitomo Pharma Co. Ltd., Neurocrine Biosciences Inc., Harmony Biosciences Holdings Inc., Vanda Pharmaceuticals Inc.

Access The Complete Sleep Disorder Market Report:

https://www.thebusinessresearchcompany.com/report/sleep-disorder-market-report

Which Region Leads The Sleep Disorder Market By Size?

North America was the largest region in the sleep disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleep disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Sleep Disorder Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=30744&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model